PDLI

PDL BioPharma, Inc. Press Releases

$8.26
*  
0.09
1.1%
Get PDLI Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading PDLI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Inc. and Certain Officers - PDLI
10/17/2014 2:02:00 PM - Market Wire


Deadline in Lawsuit for Investors in PDL BioPharma Inc (PDLI) Shares Announced by Shareholders Foundation
10/14/2014 10:15:00 AM - GlobeNewswire


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In PDL BioPharma, Inc. (PDLI) To Contact The Firm
10/10/2014 6:37:00 PM - PR Newswire
▲9.26 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PDL Announces Appointment of PricewaterhouseCoopers LLP as its New Independent Registered Public Accounting Firm
10/8/2014 9:00:00 AM - PR Newswire


PDL BioPharma Bolsters Management Team
10/6/2014 7:00:00 AM - PR Newswire


Pittsburgh Law Office of Alfred G. Yates Jr., PC Reminds Ocwen Financial Corporation (OCN) Investors of Important Class Action Deadline, and Announces Investigations of Athlon Energy (ATHL), Bankrate (RATE), Dresser-Rand Group (DRC), Move (MOVE), PDL BioP
10/6/2014 6:00:00 AM - PR Newswire


PDL BIOPHARMA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PDL BioPharma, Inc.
9/29/2014 7:44:00 PM - PR Newswire


Lifshitz & Miller Law Firm Announces Investigation of CommVault Systems, Inc., Dresser-Rand Group Inc., PDL BioPharma, Inc., Santander Consumer USA Holdings Inc., Sigma-Aldrich Corporation, and Viasystems Group, Inc.
9/24/2014 6:46:00 PM - PR Newswire


PDL BioPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
9/24/2014 12:04:00 PM - Business Wire


PDL BioPharma Responds to Class Action Lawsuit
9/23/2014 9:00:00 AM - PR Newswire


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in PDL BioPharma, Inc. (PDLI) to Contact the Firm
9/22/2014 9:30:00 AM - Market Wire


Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
9/19/2014 8:10:00 PM - PR Newswire


Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against PDL BioPharma, Inc. -- PDLI
9/19/2014 8:00:00 PM - GlobeNewswire


PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors
9/17/2014 5:57:00 PM - PR Newswire


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI
9/17/2014 2:33:00 PM - PR Newswire


PDL BioPharma Completes Regular Quarterly Dividend Payment
9/15/2014 12:05:00 PM - PR Newswire


PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
9/4/2014 4:02:00 PM - PR Newswire


PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results
8/18/2014 4:09:00 PM - PR Newswire


PDL BioPharma Announces Plans to Issue Second Quarter Financial Results After Market Today and Reschedules Earnings Call for Tuesday, August 19 at 4:30pm EDT
8/18/2014 7:00:00 AM - PR Newswire


PDL BioPharma Announces Delay in Filing Quarterly Report on Form 10-Q
8/8/2014 3:20:00 PM - PR Newswire


PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit
7/30/2014 7:00:00 AM - PR Newswire


PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014
7/28/2014 7:00:00 AM - PR Newswire